Oculis Holding AG OCS
NASDAQ OCS
$12.15 -0.02 (-0.12%)
As of: Sep 4, 2026 · 3:14 PM EDT

Oculis Holding AG (OCS) Shares Outstanding (Entity) (2020 - 2025)

Analysis

Oculis Holding AG (OCS) Shares Outstanding (Entity) (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 214.24 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 575.00 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
10 Oculis Holding AG 634.23 Mn 345.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 52.24 Mn
Dec 31, 2024 40.41 Mn
Dec 31, 2023 29.90 Mn
Dec 31, 2021 15.08 Mn
Dec 31, 2020 2.32 Mn